+关注
定位心海的锚
暂无个人介绍
IP属地：浙江
12
关注
0
粉丝
3
主题
0
勋章
主贴
热门
定位心海的锚
2021-08-19
？
*高盛微升兆科眼科(06622)目标价0.3%至20.35港元 评级“买入”
定位心海的锚
2021-06-24
本来以为平台上的东西都会比较贵，而且派送路程上的因素比较多。怕东西不新鲜。因为打新接触到每日优鲜平台，看着东西和日常也差不多，还方便很多，尝试一下。期待体验！
$每日优鲜(MF)$
定位心海的锚
2021-06-01
回发行就不错了。还20.29
高盛首予兆科眼科-B(06622.HK)「买入」评级 目标价20.29元
去老虎APP查看更多动态
{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3576884508574632","uuid":"3576884508574632","gmtCreate":1613791433714,"gmtModify":1622516428665,"name":"定位心海的锚","pinyin":"dwxhdmdingweixinhaidemao","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/f4724c34b859ffe87fa6c33f3807576b","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":0,"headSize":12,"tweetSize":3,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":3,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-2","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"资深虎友","description":"加入老虎社区1000天","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.11.22","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":2,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":"浙江","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":831554683,"gmtCreate":1629337030542,"gmtModify":1629337030542,"author":{"id":"3576884508574632","authorId":"3576884508574632","name":"定位心海的锚","avatar":"https://static.tigerbbs.com/f4724c34b859ffe87fa6c33f3807576b","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576884508574632","authorIdStr":"3576884508574632"},"themes":[],"htmlText":"？","listText":"？","text":"？","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/831554683","repostId":"2160975673","repostType":2,"repost":{"id":"2160975673","kind":"highlight","weMediaInfo":{"introduction":"凤凰网港股","home_visible":1,"media_name":"凤凰网港股","id":"1039806269","head_image":"https://static.tigerbbs.com/b6fb647077f1ce46dc341fc35c26e817"},"pubTimestamp":1629335915,"share":"https://www.laohu8.com/m/news/2160975673?lang=&edition=full","pubTime":"2021-08-19 09:18","market":"hk","language":"zh","title":"*高盛微升兆科眼科(06622)目标价0.3%至20.35港元 评级“买入”","url":"https://stock-news.laohu8.com/highlight/detail?id=2160975673","media":"凤凰网港股","summary":"凤凰网港股|高盛将兆科眼科(06622)目标价由20.29港元提升至20.35港元，评级“买入”。","content":"<html><body><p>凤凰网港股|<a href=\"https://laohu8.com/S/GS\">高盛</a>将兆科眼科(06622)目标价由20.29港元提升至20.35港元，评级“买入”。</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>*高盛微升兆科眼科(06622)目标价0.3%至20.35港元 评级“买入”</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n*高盛微升兆科眼科(06622)目标价0.3%至20.35港元 评级“买入”\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1039806269\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/b6fb647077f1ce46dc341fc35c26e817);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">凤凰网港股 </p>\n<p class=\"h-time\">2021-08-19 09:18</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>凤凰网港股|<a href=\"https://laohu8.com/S/GS\">高盛</a>将兆科眼科(06622)目标价由20.29港元提升至20.35港元，评级“买入”。</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/1b3684302211042d481cacf9066fbcca","relate_stocks":{"06622":"兆科眼科-B"},"source_url":"http://hknews.szfuit.com/newRssInfo/feed?original_id=388d5e6ff3f0cfd74a4ffdce3239c552","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2160975673","content_text":"凤凰网港股|高盛将兆科眼科(06622)目标价由20.29港元提升至20.35港元，评级“买入”。","news_type":1},"isVote":1,"tweetType":1,"viewCount":477,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":128337377,"gmtCreate":1624501209499,"gmtModify":1624501209499,"author":{"id":"3576884508574632","authorId":"3576884508574632","name":"定位心海的锚","avatar":"https://static.tigerbbs.com/f4724c34b859ffe87fa6c33f3807576b","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576884508574632","authorIdStr":"3576884508574632"},"themes":[],"htmlText":"本来以为平台上的东西都会比较贵，而且派送路程上的因素比较多。怕东西不新鲜。因为打新接触到每日优鲜平台，看着东西和日常也差不多，还方便很多，尝试一下。期待体验！<a href=\"https://laohu8.com/S/MF\">$每日优鲜(MF)$</a>","listText":"本来以为平台上的东西都会比较贵，而且派送路程上的因素比较多。怕东西不新鲜。因为打新接触到每日优鲜平台，看着东西和日常也差不多，还方便很多，尝试一下。期待体验！<a href=\"https://laohu8.com/S/MF\">$每日优鲜(MF)$</a>","text":"本来以为平台上的东西都会比较贵，而且派送路程上的因素比较多。怕东西不新鲜。因为打新接触到每日优鲜平台，看着东西和日常也差不多，还方便很多，尝试一下。期待体验！$每日优鲜(MF)$","images":[{"img":"https://static.tigerbbs.com/138d792b015f5f4ffa5535f84a38ab88","width":"1080","height":"2400"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/128337377","isVote":1,"tweetType":1,"viewCount":1487,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":119943210,"gmtCreate":1622515372530,"gmtModify":1622515372530,"author":{"id":"3576884508574632","authorId":"3576884508574632","name":"定位心海的锚","avatar":"https://static.tigerbbs.com/f4724c34b859ffe87fa6c33f3807576b","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576884508574632","authorIdStr":"3576884508574632"},"themes":[],"htmlText":"回发行就不错了。还20.29","listText":"回发行就不错了。还20.29","text":"回发行就不错了。还20.29","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/119943210","repostId":"2140457860","repostType":2,"repost":{"id":"2140457860","kind":"news","pubTimestamp":1622512131,"share":"https://www.laohu8.com/m/news/2140457860?lang=&edition=full","pubTime":"2021-06-01 09:48","market":"us","language":"zh","title":"高盛首予兆科眼科-B(06622.HK)「买入」评级 目标价20.29元","url":"https://stock-news.laohu8.com/highlight/detail?id=2140457860","media":"AAFN","summary":"高盛发表报告表示，看好兆科眼科-B 业务增长前景，主因内地眼科药物市场的巨大增长潜力、公司的创新和多目标管道辅以仿制药以及其作为全球眼科资产进入内地渠道的潜力等因素，首予其「买入」评级 及目标价20.29元。(sw/k)~阿思达克财经新闻网址: www.aastocks.com","content":"<html><body><p><a href=\"https://laohu8.com/S/GS\">高盛</a>发表报告表示，看好<a href=\"https://laohu8.com/S/06622\">兆科眼科-B</a> 业务增长前景，主因内地眼科药物市场的巨大增长潜力、公司的创新和多目标管道辅以仿制药以及其作为全球眼科资产进入内地渠道的潜力等因素，首予其「买入」评级 及目标价20.29元。(sw/k)~阿思达克财经新闻网址: www.aastocks.com</p></body></html>","source":"aastocks","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>高盛首予兆科眼科-B(06622.HK)「买入」评级 目标价20.29元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n高盛首予兆科眼科-B(06622.HK)「买入」评级 目标价20.29元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-01 09:48 北京时间 <a href=http://www.aastocks.com/apps/data/iphone/news/newscontent.aspx?newsid=NOW.1102412&style=5&chgstyle=1&categoryid=stock&width=320&market_id=hk&fontary=3&platform=iPhone&language=sc&isfirstreq=1&sourceid=aafn&datatype=0><strong>AAFN</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>高盛发表报告表示，看好兆科眼科-B 业务增长前景，主因内地眼科药物市场的巨大增长潜力、公司的创新和多目标管道辅以仿制药以及其作为全球眼科资产进入内地渠道的潜力等因素，首予其「买入」评级 及目标价20.29元。(sw/k)~阿思达克财经新闻网址: www.aastocks.com</p>\n\n<a href=\"http://www.aastocks.com/apps/data/iphone/news/newscontent.aspx?newsid=NOW.1102412&style=5&chgstyle=1&categoryid=stock&width=320&market_id=hk&fontary=3&platform=iPhone&language=sc&isfirstreq=1&sourceid=aafn&datatype=0\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/4b6684517506a0b0f4c4c5a1c4889261","relate_stocks":{"06622":"兆科眼科-B"},"source_url":"http://www.aastocks.com/apps/data/iphone/news/newscontent.aspx?newsid=NOW.1102412&style=5&chgstyle=1&categoryid=stock&width=320&market_id=hk&fontary=3&platform=iPhone&language=sc&isfirstreq=1&sourceid=aafn&datatype=0","is_english":false,"share_image_url":"https://static.laohu8.com/51f6b9126f36f92bbf92982596066e5a","article_id":"2140457860","content_text":"高盛发表报告表示，看好兆科眼科-B 业务增长前景，主因内地眼科药物市场的巨大增长潜力、公司的创新和多目标管道辅以仿制药以及其作为全球眼科资产进入内地渠道的潜力等因素，首予其「买入」评级 及目标价20.29元。(sw/k)~阿思达克财经新闻网址: www.aastocks.com","news_type":1},"isVote":1,"tweetType":1,"viewCount":1094,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":831554683,"gmtCreate":1629337030542,"gmtModify":1629337030542,"author":{"id":"3576884508574632","authorId":"3576884508574632","name":"定位心海的锚","avatar":"https://static.tigerbbs.com/f4724c34b859ffe87fa6c33f3807576b","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576884508574632","authorIdStr":"3576884508574632"},"themes":[],"htmlText":"？","listText":"？","text":"？","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/831554683","repostId":"2160975673","repostType":2,"repost":{"id":"2160975673","kind":"highlight","weMediaInfo":{"introduction":"凤凰网港股","home_visible":1,"media_name":"凤凰网港股","id":"1039806269","head_image":"https://static.tigerbbs.com/b6fb647077f1ce46dc341fc35c26e817"},"pubTimestamp":1629335915,"share":"https://www.laohu8.com/m/news/2160975673?lang=&edition=full","pubTime":"2021-08-19 09:18","market":"hk","language":"zh","title":"*高盛微升兆科眼科(06622)目标价0.3%至20.35港元 评级“买入”","url":"https://stock-news.laohu8.com/highlight/detail?id=2160975673","media":"凤凰网港股","summary":"凤凰网港股|高盛将兆科眼科(06622)目标价由20.29港元提升至20.35港元，评级“买入”。","content":"<html><body><p>凤凰网港股|<a href=\"https://laohu8.com/S/GS\">高盛</a>将兆科眼科(06622)目标价由20.29港元提升至20.35港元，评级“买入”。</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>*高盛微升兆科眼科(06622)目标价0.3%至20.35港元 评级“买入”</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n*高盛微升兆科眼科(06622)目标价0.3%至20.35港元 评级“买入”\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1039806269\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/b6fb647077f1ce46dc341fc35c26e817);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">凤凰网港股 </p>\n<p class=\"h-time\">2021-08-19 09:18</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>凤凰网港股|<a href=\"https://laohu8.com/S/GS\">高盛</a>将兆科眼科(06622)目标价由20.29港元提升至20.35港元，评级“买入”。</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/1b3684302211042d481cacf9066fbcca","relate_stocks":{"06622":"兆科眼科-B"},"source_url":"http://hknews.szfuit.com/newRssInfo/feed?original_id=388d5e6ff3f0cfd74a4ffdce3239c552","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2160975673","content_text":"凤凰网港股|高盛将兆科眼科(06622)目标价由20.29港元提升至20.35港元，评级“买入”。","news_type":1},"isVote":1,"tweetType":1,"viewCount":477,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":128337377,"gmtCreate":1624501209499,"gmtModify":1624501209499,"author":{"id":"3576884508574632","authorId":"3576884508574632","name":"定位心海的锚","avatar":"https://static.tigerbbs.com/f4724c34b859ffe87fa6c33f3807576b","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576884508574632","authorIdStr":"3576884508574632"},"themes":[],"htmlText":"本来以为平台上的东西都会比较贵，而且派送路程上的因素比较多。怕东西不新鲜。因为打新接触到每日优鲜平台，看着东西和日常也差不多，还方便很多，尝试一下。期待体验！<a href=\"https://laohu8.com/S/MF\">$每日优鲜(MF)$</a>","listText":"本来以为平台上的东西都会比较贵，而且派送路程上的因素比较多。怕东西不新鲜。因为打新接触到每日优鲜平台，看着东西和日常也差不多，还方便很多，尝试一下。期待体验！<a href=\"https://laohu8.com/S/MF\">$每日优鲜(MF)$</a>","text":"本来以为平台上的东西都会比较贵，而且派送路程上的因素比较多。怕东西不新鲜。因为打新接触到每日优鲜平台，看着东西和日常也差不多，还方便很多，尝试一下。期待体验！$每日优鲜(MF)$","images":[{"img":"https://static.tigerbbs.com/138d792b015f5f4ffa5535f84a38ab88","width":"1080","height":"2400"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/128337377","isVote":1,"tweetType":1,"viewCount":1487,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":119943210,"gmtCreate":1622515372530,"gmtModify":1622515372530,"author":{"id":"3576884508574632","authorId":"3576884508574632","name":"定位心海的锚","avatar":"https://static.tigerbbs.com/f4724c34b859ffe87fa6c33f3807576b","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576884508574632","authorIdStr":"3576884508574632"},"themes":[],"htmlText":"回发行就不错了。还20.29","listText":"回发行就不错了。还20.29","text":"回发行就不错了。还20.29","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/119943210","repostId":"2140457860","repostType":2,"repost":{"id":"2140457860","kind":"news","pubTimestamp":1622512131,"share":"https://www.laohu8.com/m/news/2140457860?lang=&edition=full","pubTime":"2021-06-01 09:48","market":"us","language":"zh","title":"高盛首予兆科眼科-B(06622.HK)「买入」评级 目标价20.29元","url":"https://stock-news.laohu8.com/highlight/detail?id=2140457860","media":"AAFN","summary":"高盛发表报告表示，看好兆科眼科-B 业务增长前景，主因内地眼科药物市场的巨大增长潜力、公司的创新和多目标管道辅以仿制药以及其作为全球眼科资产进入内地渠道的潜力等因素，首予其「买入」评级 及目标价20.29元。(sw/k)~阿思达克财经新闻网址: www.aastocks.com","content":"<html><body><p><a href=\"https://laohu8.com/S/GS\">高盛</a>发表报告表示，看好<a href=\"https://laohu8.com/S/06622\">兆科眼科-B</a> 业务增长前景，主因内地眼科药物市场的巨大增长潜力、公司的创新和多目标管道辅以仿制药以及其作为全球眼科资产进入内地渠道的潜力等因素，首予其「买入」评级 及目标价20.29元。(sw/k)~阿思达克财经新闻网址: www.aastocks.com</p></body></html>","source":"aastocks","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>高盛首予兆科眼科-B(06622.HK)「买入」评级 目标价20.29元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n高盛首予兆科眼科-B(06622.HK)「买入」评级 目标价20.29元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-01 09:48 北京时间 <a href=http://www.aastocks.com/apps/data/iphone/news/newscontent.aspx?newsid=NOW.1102412&style=5&chgstyle=1&categoryid=stock&width=320&market_id=hk&fontary=3&platform=iPhone&language=sc&isfirstreq=1&sourceid=aafn&datatype=0><strong>AAFN</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>高盛发表报告表示，看好兆科眼科-B 业务增长前景，主因内地眼科药物市场的巨大增长潜力、公司的创新和多目标管道辅以仿制药以及其作为全球眼科资产进入内地渠道的潜力等因素，首予其「买入」评级 及目标价20.29元。(sw/k)~阿思达克财经新闻网址: www.aastocks.com</p>\n\n<a href=\"http://www.aastocks.com/apps/data/iphone/news/newscontent.aspx?newsid=NOW.1102412&style=5&chgstyle=1&categoryid=stock&width=320&market_id=hk&fontary=3&platform=iPhone&language=sc&isfirstreq=1&sourceid=aafn&datatype=0\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/4b6684517506a0b0f4c4c5a1c4889261","relate_stocks":{"06622":"兆科眼科-B"},"source_url":"http://www.aastocks.com/apps/data/iphone/news/newscontent.aspx?newsid=NOW.1102412&style=5&chgstyle=1&categoryid=stock&width=320&market_id=hk&fontary=3&platform=iPhone&language=sc&isfirstreq=1&sourceid=aafn&datatype=0","is_english":false,"share_image_url":"https://static.laohu8.com/51f6b9126f36f92bbf92982596066e5a","article_id":"2140457860","content_text":"高盛发表报告表示，看好兆科眼科-B 业务增长前景，主因内地眼科药物市场的巨大增长潜力、公司的创新和多目标管道辅以仿制药以及其作为全球眼科资产进入内地渠道的潜力等因素，首予其「买入」评级 及目标价20.29元。(sw/k)~阿思达克财经新闻网址: www.aastocks.com","news_type":1},"isVote":1,"tweetType":1,"viewCount":1094,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}
